129 related articles for article (PubMed ID: 36148632)
1. Phosphoproteomics of extracellular vesicles integrated with multiomics analysis reveals novel kinase networks for lung cancer.
Qiao Z; Kong Y; Zhang Y; Qian L; Wang Z; Guan X; Lu H; Xiao H
Mol Carcinog; 2022 Dec; 61(12):1116-1127. PubMed ID: 36148632
[TBL] [Abstract][Full Text] [Related]
2. Proteomics and Phosphoproteomics of Circulating Extracellular Vesicles Provide New Insights into Diabetes Pathobiology.
Nunez Lopez YO; Iliuk A; Petrilli AM; Glass C; Casu A; Pratley RE
Int J Mol Sci; 2022 May; 23(10):. PubMed ID: 35628588
[TBL] [Abstract][Full Text] [Related]
3. Quantitative phosphoproteomic profiling of human non-small cell lung cancer tumors.
Schweppe DK; Rigas JR; Gerber SA
J Proteomics; 2013 Oct; 91():286-96. PubMed ID: 23911959
[TBL] [Abstract][Full Text] [Related]
4. [Affinity chromatography based phosphoproteome research on lung cancer cells and its application].
Zhang B; Wang C; Guo M; Xiao H
Se Pu; 2021 Jan; 39(1):77-86. PubMed ID: 34227361
[TBL] [Abstract][Full Text] [Related]
5. FAM3C in circulating tumor-derived extracellular vesicles promotes non-small cell lung cancer growth in secondary sites.
Thuya WL; Kong LR; Syn NL; Ding LW; Cheow ESH; Wong RTX; Wang T; Goh RMW; Song H; Jayasinghe MK; Le MT; Hu JC; Yong WP; Lee SC; Wong AL; Sethi G; Hung HT; Ho PC; Thiery JP; Sze SK; Guo T; Soo RA; Yang H; Lim YC; Wang L; Goh BC
Theranostics; 2023; 13(2):621-638. PubMed ID: 36632230
[No Abstract] [Full Text] [Related]
6. Titanium(IV) immobilized affinity chromatography facilitated phosphoproteomics analysis of salivary extracellular vesicles for lung cancer.
Wahid A; Sohail A; Wang H; Guo M; Zhang L; Ji Y; Wang P; Xiao H
Anal Bioanal Chem; 2022 May; 414(12):3697-3708. PubMed ID: 35306568
[TBL] [Abstract][Full Text] [Related]
7. The proteome and phosphoproteome of circulating extracellular vesicle-enriched preparations are associated with characteristic clinical features in type 1 diabetes.
Casu A; Nunez Lopez YO; Yu G; Clifford C; Bilal A; Petrilli AM; Cornnell H; Carnero EA; Bhatheja A; Corbin KD; Iliuk A; Maahs DM; Pratley RE
Front Endocrinol (Lausanne); 2023; 14():1219293. PubMed ID: 37576973
[TBL] [Abstract][Full Text] [Related]
8. Phosphoproteins in extracellular vesicles as candidate markers for breast cancer.
Chen IH; Xue L; Hsu CC; Paez JS; Pan L; Andaluz H; Wendt MK; Iliuk AB; Zhu JK; Tao WA
Proc Natl Acad Sci U S A; 2017 Mar; 114(12):3175-3180. PubMed ID: 28270605
[TBL] [Abstract][Full Text] [Related]
9. Loading MicroRNA-376c in Extracellular Vesicles Inhibits Properties of Non-Small Cell Lung Cancer Cells by Targeting YTHDF1.
Zhou J; Xiao D; Qiu T; Li J; Liu Z
Technol Cancer Res Treat; 2020; 19():1533033820977525. PubMed ID: 33280517
[TBL] [Abstract][Full Text] [Related]
10. Phosphoproteomics identifies oncogenic Ras signaling targets and their involvement in lung adenocarcinomas.
Sudhir PR; Hsu CL; Wang MJ; Wang YT; Chen YJ; Sung TY; Hsu WL; Yang UC; Chen JY
PLoS One; 2011; 6(5):e20199. PubMed ID: 21637843
[TBL] [Abstract][Full Text] [Related]
11. Effects of gefitinib treatment on cellular uptake of extracellular vesicles in EGFR-mutant non-small cell lung cancer cells.
Takenaka T; Nakai S; Katayama M; Hirano M; Ueno N; Noguchi K; Takatani-Nakase T; Fujii I; Kobayashi SS; Nakase I
Int J Pharm; 2019 Dec; 572():118762. PubMed ID: 31610280
[TBL] [Abstract][Full Text] [Related]
12. Unique Protein Profiles of Extracellular Vesicles as Diagnostic Biomarkers for Early and Advanced Non-Small Cell Lung Cancer.
An T; Qin S; Sun D; Huang Y; Hu Y; Li S; Zhang H; Li B; Situ B; Lie L; Wu Y; Zheng L
Proteomics; 2019 Jun; 19(12):e1800160. PubMed ID: 30950185
[TBL] [Abstract][Full Text] [Related]
13. A facile "one-material" strategy for tandem enrichment of small extracellular vesicles phosphoproteome.
Jiao F; Gao F; Liu Y; Fan Z; Xiang X; Xia C; Lv Y; Xie Y; Bai H; Zhang W; Qin W; Qian X
Talanta; 2021 Feb; 223(Pt 2):121776. PubMed ID: 33298282
[TBL] [Abstract][Full Text] [Related]
14. Selective sorting and secretion of hY4 RNA fragments into extracellular vesicles mediated by methylated YBX1 to promote lung cancer progression.
Li C; Wang W; Sun Y; Ni Y; Qin F; Li X; Wang T; Guo M; Sun G
J Exp Clin Cancer Res; 2022 Apr; 41(1):136. PubMed ID: 35410432
[TBL] [Abstract][Full Text] [Related]
15. Chemical Affinity-Based Isolation of Extracellular Vesicles from Biofluids for Proteomics and Phosphoproteomics Analysis.
Liu YK; Luo Z; Iliuk A; Tao WA
J Vis Exp; 2023 Oct; (200):. PubMed ID: 37955372
[TBL] [Abstract][Full Text] [Related]
16. Extracellular Vesicles from
Janpipatkul K; Panvongsa W; Worakitchanon W; Reungwetwattana T; Chairoungdua A
Anticancer Res; 2022 Aug; 42(8):3835-3844. PubMed ID: 35896267
[TBL] [Abstract][Full Text] [Related]
17. Human umbilical vein endothelial cells-derived microRNA-203-containing extracellular vesicles alleviate non-small-cell lung cancer progression through modulating the DTL/p21 axis.
Ma T; Hu Y; Guo Y; Zhang Q
Cancer Gene Ther; 2022 Jan; 29(1):87-100. PubMed ID: 33558703
[TBL] [Abstract][Full Text] [Related]
18. Reduction of miR-744 delivered by NSCLC cell-derived extracellular vesicles upregulates SUV39H1 to promote NSCLC progression via activation of the Smad9/BMP9 axis.
Gao L; Tian Q; Wu T; Shi S; Yin X; Liu L; Zheng L; Wang P; Tian Y; Xu S
J Transl Med; 2021 Jan; 19(1):37. PubMed ID: 33472665
[TBL] [Abstract][Full Text] [Related]
19. APE1 shRNA-loaded cancer stem cell-derived extracellular vesicles reverse Erlotinib resistance in non-small cell lung cancer via the IL-6/STAT3 signalling.
Tang CH; Qin L; Gao YC; Chen TY; Xu K; Liu T; Ren T
Clin Transl Med; 2022 May; 12(5):e876. PubMed ID: 35605028
[TBL] [Abstract][Full Text] [Related]
20. Phosphoproteomics reveals network rewiring to a pro-adhesion state in annexin-1-deficient mammary epithelial cells.
Alli-Shaik A; Wee S; Lim LHK; Gunaratne J
Breast Cancer Res; 2017 Dec; 19(1):132. PubMed ID: 29233185
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
